Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg), Immunologic Deficiency Syndromes, Date of authorisation: 14/04/2011, Revision: 17, Status: Authorised

Case Medical Research ◽

10.31525/cmr-119e1c5 ◽

2019 ◽

Author(s):

Keyword(s):

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Immunologic Deficiency Syndromes, Date of authorisation: 16/05/2013, Revision: 13, Status: Authorised

Case Medical Research ◽

10.31525/cmr-27f9222 ◽

2020 ◽

Author(s):

Keyword(s):

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Mucocutaneous Lymph Node Syndrome,Guillain-Barre Syndrome,Bone Marrow Transplantation,Purpura, Thrombocytopenic, Idiopathic,Immunologic Deficiency Syndromes, Date of authorisation: 23/07/2007, Revision: 17, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1d27132 ◽

2019 ◽

Author(s):

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Marrow Transplantation ◽

Mucocutaneous Lymph Node Syndrome ◽

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Lymph Node Syndrome

Download Full-text

Human medicines European public assessment report (EPAR): Privigen, human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 24/04/2008, Revision: 24, Status: Authorised

Case Medical Research ◽

10.31525/cmr-58723b ◽

2019 ◽

Author(s):

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Marrow Transplantation ◽

Mucocutaneous Lymph Node Syndrome ◽

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Lymph Node Syndrome

Download Full-text

Human medicines European public assessment report (EPAR): Kiovig, human normal immunoglobulin, Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 18/01/2006, Revision: 23, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871a4 ◽

2019 ◽

Author(s):

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Marrow Transplantation ◽

Mucocutaneous Lymph Node Syndrome ◽

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Lymph Node Syndrome

Download Full-text

Human medicines European public assessment report (EPAR): Kiovig, human normal immunoglobulin, Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 18/01/2006, Revision: 21, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5014c5 ◽

2019 ◽

Author(s):

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Marrow Transplantation ◽

Mucocutaneous Lymph Node Syndrome ◽

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Lymph Node Syndrome

Download Full-text

Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg), Immunologic Deficiency Syndromes, Date of authorisation: 14/04/2011, Revision: 18, Status: Authorised

Case Medical Research ◽

10.31525/cmr-119e08c ◽

2019 ◽

Author(s):

Keyword(s):

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Mucocutaneous Lymph Node Syndrome,Guillain-Barre Syndrome,Bone Marrow Transplantation,Purpura, Thrombocytopenic, Idiopathic,Immunologic Deficiency Syndromes, Date of authorisation: 23/07/2007, Revision: 16, Status: Authorised

Case Medical Research ◽

10.31525/cmr-977fc6 ◽

2019 ◽

Author(s):

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Marrow Transplantation ◽

Mucocutaneous Lymph Node Syndrome ◽

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Lymph Node Syndrome

Download Full-text

Human medicines European public assessment report (EPAR): Privigen, human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic,Bone Marrow Transplantation,Immunologic Deficiency Syndromes,Guillain-Barre Syndrome,Mucocutaneous Lymph Node Syndrome, Date of authorisation: 24/04/2008, Revision: 23, Status: Authorised

Case Medical Research ◽

10.31525/cmr-3996bb ◽

2019 ◽

Author(s):

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Marrow Transplantation ◽

Mucocutaneous Lymph Node Syndrome ◽

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Lymph Node Syndrome

Download Full-text

Human medicines European public assessment report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Mucocutaneous Lymph Node Syndrome,Guillain-Barre Syndrome,Bone Marrow Transplantation,Purpura, Thrombocytopenic, Idiopathic,Immunologic Deficiency Syndromes, Date of authorisation: 23/07/2007, Revision: 16, Status: Authorised

Case Medical Research ◽

10.31525/cmr-399651 ◽

2019 ◽

Author(s):

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Marrow Transplantation ◽

Mucocutaneous Lymph Node Syndrome ◽

Immunologic Deficiency Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Lymph Node Syndrome

Download Full-text

Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Fabry Disease, Date of authorisation: 03/08/2001, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-19715f1 ◽

2019 ◽

Author(s):

Keyword(s):

Fabry Disease ◽

Agalsidase Beta ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text